ATEA PHARMACEUTICALS, INC.

(AVIR)
  Rapport
Temps Différé Nasdaq  -  20/05 22:00:01
7.490 USD   +3.31%
10/05Atea Pharmaceuticals, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
CI
02/03ATEA PHARMACEUTICALS, INC. : JPMorgan Chase maintient sa recommandation neutre
ZM
01/03ATEA PHARMACEUTICALS, INC. : SVB Leerink n'est pas inspiré par le dossier
ZM
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
ETFs positionnés sur ATEA PHARMACEUTICALS, INC.ETFs et Trackers avec Trackinsight
ETF PoidsVar. 5joursRatingGéographie
SPDR S&P Pharmaceuticals ETF - USD1.11%3.14%Etats Unis
IShares Nasdaq US Biotechnology (D) - USD0.05%1.64%Etats Unis
IShares Nasdaq US Biotechnology - USD0.05%1.60%Etats Unis
IShares Biotechnology ETF - USD0.05%2.18%-NC
IShares Russell 2000 Value ETF - USD0.03%1.67%Etats Unis
IShares Russell 2000 ETF - USD0.02%2.28%Etats Unis
Xtrackers Russell 2000 1C - USD0.02%-3.33%Etats Unis
IShares Morningstar Small-Cap ETF - USD0.01%2.60%-NC
IShares Edge MSCI Multifactor USA Small-Ca...0.01%-1.36%Etats Unis



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique ATEA PHARMACEUTICALS, INC.
Durée : Période :
Atea Pharmaceuticals, Inc. : Graphique analyse technique Atea Pharmaceuticals, Inc. | Zone bourse
Graphique plein écran
Evolution du Compte de Résultat
Consensus
Vente
Achat
Recommandation moyenne CONSERVER
Nombre d'Analystes 4
Dernier Cours de Clôture 7,49 $
Objectif de cours Moyen 10,25 $
Ecart / Objectif Moyen 36,8%
Révisions de BNA
Secteur et Concurrence
Var. 1janvCapi. (M$)
ATEA PHARMACEUTICALS, INC.-16.22%624
GILEAD SCIENCES, INC.-12.08%80 075
REGENERON PHARMACEUTICALS, INC.4.69%71 235
VERTEX PHARMACEUTICALS17.76%66 136
WUXI APPTEC CO., LTD.-16.92%42 735
BIONTECH SE-36.77%39 612